SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
Yesterday 4:44 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 25-Mar-24 | Planned Option Sale | 15,000 | $66.93 | $1,003,980.00 | (2%) 790.19K to 775.19K | |
Yesterday 4:44 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 25-Mar-24 | Option Exercise | 15,000 | $1.79 | $26,850.00 | 2% 775.19K to 790.19K | |
20-Mar-24 4:29 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 18-Mar-24 | Option Exercise | 8,000 | $5.35 | $42,800.00 | 8% 95.68K to 103.68K | |
20-Mar-24 4:29 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 18-Mar-24 | Planned Option Sale | 8,000 | $69.02 | $552,144.00 | (8%) 103.68K to 95.68K | |
19-Mar-24 4:26 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 15-Mar-24 | Payment of Exercise | 1,484 | $69.70 | $103,435.00 | (< 1%) 222.77K to 221.29K | |
19-Mar-24 4:26 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 15-Mar-24 | Grant | 4,099 | -- | -- | 2% 218.67K to 222.77K | |
13-Mar-24 4:22 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 11-Mar-24 | Option Exercise | 65,000 | $2.03 | $131,950.00 | 9% 710.19K to 775.19K | |
04-Mar-24 9:21 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 02-Mar-24 | Payment of Exercise | 613 | $71.55 | $43,860.20 | (2%) 31.21K to 30.6K | |
04-Mar-24 9:22 PM View: | Cowan Elvia SVP, Finance | Vaxcyte, Inc. (PCVX) | 02-Mar-24 | Payment of Exercise | 324 | $71.55 | $23,182.20 | (3%) 12.48K to 12.16K | |
04-Mar-24 9:19 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 02-Mar-24 | Payment of Exercise | 7,967 | $71.55 | $570,039.00 | (1%) 718.15K to 710.19K | |
04-Mar-24 9:23 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 02-Mar-24 | Payment of Exercise | 2,178 | $71.55 | $155,836.00 | (< 1%) 220.85K to 218.67K | |
04-Mar-24 9:20 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 02-Mar-24 | Payment of Exercise | 3,795 | $71.55 | $271,532.00 | (4%) 99.47K to 95.68K | |
04-Mar-24 9:22 PM View: | Cowan Elvia SVP, Finance | Vaxcyte, Inc. (PCVX) | 01-Mar-24 | Planned Option Sale | 11,000 | $74.08 | $814,846.00 | (46%) 24.16K to 13.16K | |
04-Mar-24 9:22 PM View: | Cowan Elvia SVP, Finance | Vaxcyte, Inc. (PCVX) | 01-Mar-24 | Sale (Planned) | 678 | $74.08 | $50,224.20 | (5%) 13.16K to 12.48K | |
04-Mar-24 9:23 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 01-Mar-24 | Sale (Planned) | 3,000 | $73.71 | $221,134.00 | (1%) 223.85K to 220.85K | |
04-Mar-24 9:21 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 01-Mar-24 | Option Exercise | 1,667 | $21.41 | $35,690.50 | 5% 31.21K to 32.88K | |
04-Mar-24 9:22 PM View: | Cowan Elvia SVP, Finance | Vaxcyte, Inc. (PCVX) | 01-Mar-24 | Option Exercise | 11,000 | $25.92 | $285,120.00 | 84% 13.16K to 24.16K | |
04-Mar-24 9:19 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 01-Mar-24 | Sale (Planned) | 2,616 | $73.70 | $192,799.00 | (< 1%) 720.77K to 718.15K | |
04-Mar-24 9:21 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 01-Mar-24 | Planned Option Sale | 1,667 | $73.73 | $122,907.00 | (5%) 32.88K to 31.21K | |
04-Mar-24 9:22 PM View: | Cowan Elvia SVP, Finance | Vaxcyte, Inc. (PCVX) | 29-Feb-24 | Grant | 5,400 | -- | -- | 70% 7.76K to 13.16K | |
04-Mar-24 9:23 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 29-Feb-24 | Grant | 20,000 | -- | -- | 10% 203.85K to 223.85K | |
04-Mar-24 9:19 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 29-Feb-24 | Grant | 45,000 | -- | -- | 7% 675.77K to 720.77K | |
04-Mar-24 9:20 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 29-Feb-24 | Grant | 20,000 | -- | -- | 25% 79.47K to 99.47K | |
04-Mar-24 9:21 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 29-Feb-24 | Grant | 10,500 | -- | -- | 51% 20.71K to 31.21K | |
27-Feb-24 4:17 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 26-Feb-24 | Option Exercise | 30,000 | $1.79 | $53,700.00 | 4% 675.77K to 705.77K | |
27-Feb-24 4:17 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 26-Feb-24 | Planned Option Sale | 30,000 | $79.03 | $2,370,900.00 | (4%) 705.77K to 675.77K | |
27-Feb-24 4:17 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 23-Feb-24 | Planned Option Sale | 15,000 | $76.21 | $1,143,210.00 | (2%) 690.77K to 675.77K | |
27-Feb-24 4:17 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 23-Feb-24 | Option Exercise | 15,000 | $1.79 | $26,850.00 | 2% 675.77K to 690.77K | |
22-Feb-24 4:30 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 20-Feb-24 | Planned Option Sale | 8,000 | $74.53 | $596,232.00 | (9%) 87.47K to 79.47K | |
22-Feb-24 4:30 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 20-Feb-24 | Option Exercise | 8,000 | $5.35 | $42,800.00 | 10% 79.47K to 87.47K | |
20-Feb-24 4:22 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 15-Feb-24 | Option Exercise | 27,917 | $2.42 | $67,559.10 | 16% 175.94K to 203.85K | |
05-Feb-24 5:39 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 01-Feb-24 | Planned Private Option Sale | 1,667 | $73.87 | $123,144.00 | (7%) 22.38K to 20.71K | |
05-Feb-24 5:37 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 01-Feb-24 | Option Exercise | 3,000 | $2.42 | $7,260.00 | 2% 175.94K to 178.94K | |
05-Feb-24 5:37 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 01-Feb-24 | Planned Option Sale | 3,000 | $73.88 | $221,626.00 | (2%) 178.94K to 175.94K | |
05-Feb-24 5:33 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 01-Feb-24 | Private Sale (Planned) | 2,616 | $73.91 | $193,353.00 | (< 1%) 678.39K to 675.77K | |
05-Feb-24 5:39 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 01-Feb-24 | Option Exercise | 1,667 | $21.41 | $35,690.50 | 8% 20.71K to 22.38K | 6% |
02-Feb-24 4:40 PM View: | Lukatch Heath Director | Vaxcyte, Inc. (PCVX) | 31-Jan-24 | Option Exercise | 5,000 | $16.00 | $80,000.00 | 89% 5.63K to 10.63K | |
02-Feb-24 4:40 PM View: | Lukatch Heath Director | Vaxcyte, Inc. (PCVX) | 31-Jan-24 | Planned Option Sale | 5,000 | $71.50 | $357,500.00 | (47%) 10.63K to 5.63K | |
31-Jan-24 4:11 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 29-Jan-24 | Option Exercise | 30,000 | $1.79 | $53,700.00 | 4% 678.39K to 708.39K | |
31-Jan-24 4:11 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 29-Jan-24 | Planned Option Sale | 30,000 | $66.03 | $1,980,900.00 | (4%) 708.39K to 678.39K | |
31-Jan-24 4:12 PM View: | Lukatch Heath Director | Vaxcyte, Inc. (PCVX) | 29-Jan-24 | Option Exercise | 4,000 | $16.00 | $64,000.00 | 71% 5.63K to 9.63K | |
31-Jan-24 4:12 PM View: | Lukatch Heath Director | Vaxcyte, Inc. (PCVX) | 29-Jan-24 | Planned Option Sale | 4,000 | $67.50 | $270,000.00 | (42%) 9.63K to 5.63K | |
25-Jan-24 5:50 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 23-Jan-24 | Planned Option Sale | 15,000 | $63.92 | $958,783.00 | (2%) 693.39K to 678.39K | |
25-Jan-24 5:50 PM View: | Pickering Grant Chief Executive Officer Director | Vaxcyte, Inc. (PCVX) | 23-Jan-24 | Option Exercise | 15,000 | $1.44 | $21,600.00 | 2% 678.39K to 693.39K | |
19-Jan-24 4:17 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 18-Jan-24 | Option Exercise | 8,000 | $5.35 | $42,800.00 | 10% 79.47K to 87.47K | |
19-Jan-24 4:17 PM View: | Guggenhime Andrew President and CFO | Vaxcyte, Inc. (PCVX) | 18-Jan-24 | Planned Option Sale | 8,000 | $60.73 | $485,879.00 | (9%) 87.47K to 79.47K | |
04-Jan-24 4:26 PM View: | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Vaxcyte, Inc. (PCVX) | 02-Jan-24 | Planned Private Option Sale | 1,667 | $63.93 | $106,579.00 | (7%) 22.38K to 20.71K | |
04-Jan-24 4:25 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 02-Jan-24 | Option Exercise | 3,000 | $2.42 | $7,260.00 | 2% 175.94K to 178.94K | |
04-Jan-24 4:25 PM View: | Wassil Jim Chief Operating Officer | Vaxcyte, Inc. (PCVX) | 02-Jan-24 | Planned Option Sale | 3,000 | $63.91 | $191,741.00 | (2%) 178.94K to 175.94K | |
04-Jan-24 4:26 PM View: | Lukatch Heath Director | Vaxcyte, Inc. (PCVX) | 02-Jan-24 | Option Exercise | 13,000 | $16.00 | $208,000.00 | 231% 5.63K to 18.63K |